Search
Sanara Medtech Inc
SMTIAdd to Watchlist
35.100USD
-0.050-0.14%
Close 09-24 16:00（ET）
322.57MMarket Cap
LossP/E TTM
Sanara Medtech Inc (SMTI) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Sanara Medtech Inc in the past month.
Hold
0 Strong Buy
0 Buy
3 Hold
0 Sell
0 Strong Sell
Target Price
35.000USD-0.43%
SMTI Analyst Recommendation Trends
In the current month, SMTI has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. SMTI average Analyst price target in the last month is 35.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
3
2
2
1
2
2
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
2
2
1
2
2
SMTI Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, SMTI EPS is projected to reach 0.060 in FY2026Q3, following reported EPS of -0.052 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.11
-0.13
-0.03
0.06
0.14
Actual
-0.19
0.05
-0.05
--
--
Surprise
-268.99%
+140.55%
-109.12%
--
--
FAQs
What is Sanara Medtech Inc's expected revenue for the next quarter?
Sanara Medtech Inc's expected revenue is 29.67M.
What is Sanara Medtech Inc's price target?
Analysts forecast that Sanara Medtech Inc's price target is USD 35.00, with the highest forecast at USD 35.00 and the lowest forecast at USD 35.00.
How have Sanara Medtech IncSMTI's recent earnings per share performed?
The market expectation was USD -0.05, while Sanara Medtech IncSMTI's earnings per share (EPS) for the previous quarter was USD 0.05. EPS for the next quarter is expected at USD 0.06.
What is the analyst rating for Sanara Medtech Inc?
Based on the ratings of Sanara Medtech Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.